CLARADOL CAFEINE 500 mg/50 mg, effervescent tablet 16 tablets
Active ingredients: Caffeine, Paracetamol
Commercialized according to BDPM
Effervescent tablet16 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- CLARADOL CAFEINE 500 mg/50 mg, comprimé effervescent
- Pharmaceutical form
- comprimé effervescent(e)
- Route of administration
- orale
- Presentation description
- film(s) thermosoudé(s) aluminium polyéthylène de 16 comprimé(s)
- Marketing authorisation holder
- TEOFARMA
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 31 Mar 2023
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62074559CIP73320797CIP133400933207977Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CAFÉINEcomprimé | 50 mg · un comprimé | SA |
| PARACÉTAMOLcomprimé | 500 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.